Related references
Note: Only part of the references are listed.Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis
Eva Salgado et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies
Eva Salgado et al.
JOINT BONE SPINE (2014)
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
John D. Isaacs et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Performance of Anti-Cyclic Citrullinated Peptide Assays Differs in Subjects at Increased Risk of Rheumatoid Arthritis and Subjects With Established Disease
M. Kristen Demoruelle et al.
ARTHRITIS AND RHEUMATISM (2013)
Somatic Hypermutations Confer Rheumatoid Factor Activity in Hepatitis C Virus-Associated Mixed Cryoglobulinemia
Edgar D. Charles et al.
ARTHRITIS AND RHEUMATISM (2013)
Is rheumatoid factor useful in primary care? A retrospective cross-sectional study
Anne Miller et al.
CLINICAL RHEUMATOLOGY (2013)
Clinical Use of Anti-Cyclic Citrullinated Peptide Antibody Testing
Christine Peoples et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2013)
Rheumatoid Factor B Cell Memory Leads to Rapid, Switched Antibody-Forming Cell Responses
Rebecca A. Sweet et al.
JOURNAL OF IMMUNOLOGY (2013)
Anticitrullinated Protein Antibodies and Rheumatoid Factor Fluctuate in Early Inflammatory Arthritis and Do Not Predict Clinical Outcomes
Lillian Barra et al.
JOURNAL OF RHEUMATOLOGY (2013)
Cytokine measurements and possible interference from heterophilic antibodies - Problems and solutions experienced with rheumatoid factor
Else Marie Bartels et al.
METHODS (2013)
Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis
Cesar Faillace et al.
RHEUMATOLOGY INTERNATIONAL (2013)
The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern turkey
Turker Tasliyurt et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis
F. Debaugnies et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2013)
Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
R. J. Maneiro et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
A rheumatoid factor paradox: inhibition of rituximab effector function
Jonathan D. Jones et al.
ARTHRITIS RESEARCH & THERAPY (2013)
A case of biochemical assay discrepancy: Interference with measurement of thyroid-stimulating hormone due to rheumatoid factor
Ana Maria Ramos-Levi et al.
ENDOCRINOLOGIA Y NUTRICION (2013)
Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases
Carlo Palazzi et al.
AUTOIMMUNITY REVIEWS (2012)
Interference in Antiphospholipid Antibody Assays
Gabriella Lakos
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
The Effect of Paraproteins and Rheumatoid Factor on Four Commercial Immunoassays for Vancomycin: Implications for Laboratorians and Other Health Care Professionals
Donald F. LeGatt et al.
THERAPEUTIC DRUG MONITORING (2012)
Rheumatoid factor positivity in the general population
Julia F. Simard et al.
BRITISH MEDICAL JOURNAL (2012)
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study
Sune F. Nielsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Anti-Cyclic Citrullinated Peptide Antibody: An Early Diagnostic and Prognostic Biomarker of Rheumatoid Arthritis
D. Manivelavan et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2012)
Rheumatoid Factor and Its Interference with Cytokine Measurements: Problems and Solutions
Else Marie Bartels et al.
ARTHRITIS (2011)
The Number of Elevated Cytokines and Chemokines in Preclinical Seropositive Rheumatoid Arthritis Predicts Time to Diagnosis in an Age-Dependent Manner
Kevin D. Deane et al.
ARTHRITIS AND RHEUMATISM (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Structure and function of immunoglobulins
Harry W. Schroeder et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for Investigation
Kevin D. Deane et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2010)
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
C. Potter et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
What happens before the onset of rheumatoid arthritis?
Solbritt Rantapaa-Dahlqvist
CURRENT OPINION IN RHEUMATOLOGY (2009)
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis
Luca Quartuccio et al.
RHEUMATOLOGY (2009)
Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
Jennie Ursum et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
Mario Berth et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
HA Chen et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
VPK Nell et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment
P Caramaschi et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
L De Rycke et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Lymphoproliferative disorders in Sjogren's syndrome
Y Masaki et al.
AUTOIMMUNITY REVIEWS (2004)
Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody
TR Mikuls et al.
ARTHRITIS AND RHEUMATISM (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
S Rantapää-Dahlqvist et al.
ARTHRITIS AND RHEUMATISM (2003)
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2003)
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia
D Sansonno et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis
S Bas et al.
RHEUMATOLOGY (2003)
Regional differences in Finland in the prevalence of rheumatoid factor in the presence and absence of arthritis
T Korpilähde et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Mast cells: A cellular link between autoantibodies and inflammatory arthritis
DM Lee et al.
SCIENCE (2002)
Rheumatoid factors: Host resistance or autoimmunity?
MM Newkirk
CLINICAL IMMUNOLOGY (2002)
Share Paper
